Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Roussel Uclaf discloses integrin antagonists for bone disorders

Nov. 26, 1997

ProLease hGH slated to enter phase III

Nov. 26, 1997

Sertoli and Carolinas Medical Center collaborate to develop novel diabetes therapy

Nov. 26, 1997

FDA approves sibutramine for the treatment of obesity

Nov. 25, 1997

Bayer introduces statin in Germany

Nov. 25, 1997

Novel beta-agonists for obesity and diabetes described by SmithKline Beecham

Nov. 25, 1997

Dainippon's aldose reductase inhibitor in preclinical testing

Nov. 25, 1997

Novartis launches once-monthly formulation of Sandostatin

Nov. 24, 1997

Role of substance P in PTH secretion described

Nov. 24, 1997

GH secretagogues under development at Merck & Co.

Nov. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...